Compare ImmunityBio Inc. Common Stock (IBRX) vs iShares 3 7 Year Treasury Bond ETF (IEI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs iShares 3 7 Year Treasury Bond ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while iShares 3 7 Year Treasury Bond ETF trades at $113.56 (market cap $16.72B). The key difference: iShares 3 7 Year Treasury Bond ETF is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and iShares 3 7 Year Treasury Bond ETF for 43 Days on average.
| IBRX | IEI | |
|---|---|---|
Market Cap | $10.51B | $16.72B |
Volume | 10,445,785 | 3,963,319 |
Sector | Health | Fixed Income |
52-Week High | $11.55 | $120.72 |
52-Week Low | $1.98 | $113.17 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $10.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IEI is trading at $113.38 with minimal daily movement (+0.04%). The technical picture shows strong bearish momentum across moving averages and oscillators, with key indicators like the ADX signaling strong downward trends. Recent bond market volatility and rising Treasury yields create a challenging environment for fixed-income related investments. The company has maintained consistent dividend payments, with recent distributions of $0.37-$0.38 per share.
The outlook remains cautious given the bearish technical signals and broader bond market pressures. While dividend consistency provides some stability, the lack of available fundamental metrics and negative technical momentum suggests limited near-term upside potential. Investors should monitor Treasury yield developments and company financial disclosures for clearer directional signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About iShares 3 7 Year Treasury Bond ETF
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →
